Monday, April 12, 2021


Vaccine Research




INOVIO Receives $71 Million Contract From U.S. Department of Defense

CELLECTRA® 3PSP is designed to deliver INO-4800 directly into the skin, where the vaccine prompts the body's immune system to drive a robust immune response

This Is Why We Should NEVER Rush A Vaccine To Market

We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective

Why We Should Be Cautious With COVID-19 Medical Research

The entire world waits on pins and needles for a magic bullet to stop COVID-19 dead in its tracks. We cheer on researchers working around the clock to find a solution, a vaccine, or a cure.

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus